Projects per year
Personal profile
Biography
Laura is a Senior Research Fellow within the Centre for Health Economics, Monash Business School and the Transfusion Research Unit, Monash University.
Her qualifications include BPharm(Hons), MPH, PhD. She conducts research into the comparative effectiveness, safety and cost-effectiveness of pharmaceuticals and blood products, seeks to understand patient preferences for healthcare treatments or services and evaluates the clinical- and cost-effectiveness of pharmaceutical submissions to the Pharmaceutical Benefits Advisory Committee (PBAC). Her methodological expertise includes economic evaluation alongside clinical trials, causal inference using healthcare administrative data and discrete (stated) choice experiments.
Research interests
Health Economic Evaluation
Economics of pharmaceuticals
Pharmacoepidemiology
Health Technology Assessment
Discrete Choice Experiments
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Bachelor of Pharmacy with Honours
Master of Public Health
Doctor of Philosophy
Research area keywords
- Health Economics
- Economic Evaluation
- Pharmacoepidemiology
- Health Technology Assessments
- Decision Analytic Modelling
- Comparative Effectiveness Research
- Propensity Score Modelling
- Discrete Choice Experiments
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
OPTIMAL: OPTimising Immunoglobulin Management in Australia
Wood, E. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Petrie, D. (Chief Investigator (CI)), Bielby, L. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)), Burgner, D. (Chief Investigator (CI)), Roberts, J. A. (Chief Investigator (CI)), Van Der Walt, A. (Chief Investigator (CI)), Heiss, L. (Chief Investigator (CI)), Daly, J. (Chief Investigator (CI)), Chai, K. L. (Associate Investigator (AI)), Singh-Grewal, D. (Associate Investigator (AI)), Irving, A. (Associate Investigator (AI)), Carrillo De Albornoz San Juan, S. (Associate Investigator (AI)), Crispin, P. (Associate Investigator (AI)) & Le, T. (Associate Investigator (AI))
1/11/23 → 31/10/28
Project: Research
-
VALUE-Ig : eVidence synthesis to inform the optimAL UsE of Immunoglobulin
Petrie, D. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Harris, A. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Irving, A. (Chief Investigator (CI)), Van Der Walt, A. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Hawkes, E. (Chief Investigator (CI)) & Crispin, P. (Chief Investigator (CI))
1/04/22 → 31/03/27
Project: Research
-
Preventing infections in patients with blood cancer through evidence-based use of immunoglobulin or alternatives: The RATIONALISE trial
Wood, E. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Morrissey, O. (Chief Investigator (CI)), Trotman, J. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Opat, S. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Paterson, D. L. (Chief Investigator (CI)) & Mulligan, S. P. (Chief Investigator (CI))
1/07/21 → 30/06/26
Project: Research
-
Activating pharmacists to reduce medication related problems: The ACTMed stepped wedge randomised controlled trial
Spinks, J. M. (Primary Chief Investigator (PCI)), Nissen, L. M. (Chief Investigator (CI)), Kelly, F. S. (Chief Investigator (CI)), Wheeler, A. J. (Chief Investigator (CI)), Boyle, D. I. R. (Chief Investigator (CI)), Ware, R. S. (Chief Investigator (CI)), Petrie, D. (Chief Investigator (CI)), Byrnes, J. (Chief Investigator (CI)), Kelly, F. S. (Chief Investigator (CI)), Hall, K. (Chief Investigator (CI)) & Fanning, L. (Chief Investigator (CI))
Department of Health and Aged Care (Australia)
1/06/21 → 30/09/24
Project: Research
-
Epidemiological modelling to deliver better care for Australian patients with myeloma
McQuilten, Z. (Primary Chief Investigator (PCI)), Petrie, D. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Harris, A. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)) & Huynh, K. (Chief Investigator (CI))
1/06/20 → 31/05/24
Project: Research
-
Comparative effectiveness and safety of off-label underdosed direct oral anticoagulants in Asian patients with atrial fibrillation: a systematic review and meta-analysis
Mongkhon, P., Singkham, N., Ponok, K., Liamsrijan, N., Phoosa, W., Phattanasobhon, S., Fanning, L., Senthong, V. & Saokaew, S., 2025, In: Drug Safety. 48, p. 25-42 18 p.Research output: Contribution to journal › Article › Research › peer-review
2 Citations (Scopus) -
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry
Irving, A., Petrie, D., Harris, A., Fanning, L., Wood, E. M., Moore, E., Wellard, C., Waters, N., Huynh, K., Augustson, B., Cook, G., Gay, F., McCaughan, G., Mollee, P., Spencer, A. & McQuilten, Z. K., 27 Aug 2024, In: PLoS ONE. 19, 8, 14 p., e0308812.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies
de Albornoz, S. C., Higgins, A. M., Petrie, D., Irving, A., Fanning, L., Weinkove, R., Crispin, P., Dendle, C., Gilbertson, M., Johnston, A., Keegan, A., Pepperell, D., Pullon, H., Reynolds, J., van Tonder, T., Trotman, J., Waters, N., Wellard, C., Weston, H. & Morrissey, C. O. & 2 others, , 14 May 2024, In: Blood Advances. 8, 9, p. 2259-2267 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Activating pharmacists to reduce the frequency of medication-related problems (ACTMed): a stepped wedge cluster randomised trial
Spinks, J., Violette, R., Boyle, D. I. R., Petrie, D., Fanning, L., Hall, K. K., Kelly, F., Wheeler, A. J., Ware, R. S., Byrnes, J., Chen, E., Donald, A., Ellis, N., DelDot, M. & Nissen, L., Oct 2023, In: The Medical Journal of Australia. 219, 7, p. 325-331 7 p.Research output: Contribution to journal › Article › Other › peer-review
Open AccessFile1 Citation (Scopus) -
Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain
Wood, E. M., Chai, K. L., Reynolds, J., Griffiths, J., Beaton, B., Callum, J., Crassini, K., Crispin, P. J., Fanning, L., Gilbertson, M., Grigg, A. P., Hawkes, E. A., Morrissey, C. O., Mulligan, S. P., Opat, S. S., Paterson, D. L., Petrie, D., Roberts, J. A., Ryan, E. G. & Spencer, A. & 6 others, , 2 Nov 2023, In: Blood. 142, S1, p. 1295-1297 3 p.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access
Prizes
-
The Ronald D. Mann Best Paper Award, Pharmacoepidemiology and Drug Safety Best Papers Published in 2020, Volume 29
Fanning, L. (Recipient), Wong, I. C. K. (Recipient), Li, X. (Recipient), Chan, E. (Recipient), Mongkhon, P. (Recipient), Man, K. K. C. (Recipient), Wei, L. (Recipient), Leung, W. K. (Recipient), Darzins, P. (Recipient), Bell, S. (Recipient), Ilomaki, J. (Recipient) & Lau, W. C. Y. (Recipient), 26 Aug 2021
Prize: Prize (including medals and awards)
File